Melatonin: A novel candidate for the treatment of osteoarthritis

Y Zhang, T Liu, H Yang, F He, X Zhu - Ageing research reviews, 2022 - Elsevier
Osteoarthritis (OA), characterized by cartilage erosion, synovium inflammation, and
subchondral bone remodeling, is a common joint degenerative disease worldwide. OA …

Why is longevity still a scientific mystery? Sirtuins—past, present and future

P Ziętara, M Dziewięcka, M Augustyniak - International Journal of …, 2022 - mdpi.com
The sirtuin system consists of seven highly conserved regulatory enzymes responsible for
metabolism, antioxidant protection, and cell cycle regulation. The great interest in sirtuins is …

Trimanganese tetroxide nanozyme protects cartilage against degeneration by reducing oxidative stress in osteoarthritis

W Wang, J Duan, W Ma, B Xia, F Liu, Y Kong… - Advanced …, 2023 - Wiley Online Library
Osteoarthritis, a chronic degenerative cartilage disease, is the leading cause of movement
disorders among humans. Although the specific pathogenesis and associated mechanisms …

[HTML][HTML] SIRT1 and SIRT6: The role in aging-related diseases

Y You, W Liang - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2023 - Elsevier
Aging is characterized by progressive functional deterioration with increased risk of
mortality. It is a complex biological process driven by a multitude of intertwined mechanisms …

Aging, cell senescence, the pathogenesis and targeted therapies of osteoarthritis

XX Zhang, SH He, X Liang, W Li, TF Li… - Frontiers in …, 2021 - frontiersin.org
Osteoarthritis (OA) is a chronic, debilitating joint disease characterized by progressive
destruction of articular cartilage. For a long time, OA has been considered as a degenerative …

SIRT6 Prevents Glucocorticoid‐Induced Osteonecrosis of the Femoral Head in Rats

L Fang, G Zhang, Y Wu, Z Li, S Gao… - Oxidative Medicine and …, 2022 - Wiley Online Library
Objective. Glucocorticoid‐induced osteonecrosis of the femoral head is one of the most
common causes of nontraumatic osteonecrosis of the femoral head, but its exact …

Thioredoxin-interacting protein: A new therapeutic target in bone metabolism disorders?

N Jiang, J Liu, C Guan, C Ma, J An, X Tang - Frontiers in Immunology, 2022 - frontiersin.org
Target identification is essential for developing novel therapeutic strategies in diseases.
Thioredoxin-interacting protein (TXNIP), also known as thioredoxin-binding protein-2, is a …

Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice

JA Collins, CJ Kim, A Coleman, A Little… - Annals of the …, 2023 - ard.bmj.com
Objectives Prior studies noted that chondrocyte SIRT6 activity is repressed in older
chondrocytes rendering cells susceptible to catabolic signalling events implicated in …

Emerging therapeutic targets for osteoarthritis

E Hadzic, F Beier - Expert Opinion on Therapeutic Targets, 2023 - Taylor & Francis
Introduction Osteoarthritis is a heterogeneous joint disorder that lacks a clinically meaningful
disease modifying drug. Animal models have been beneficial in understanding basic joint …

The role of the sirtuin family in cartilage and osteoarthritis: molecular mechanisms and therapeutic targets

K Sun, Y Wu, Y Zeng, J Xu, L Wu, M Li… - Arthritis Research & …, 2022 - Springer
Osteoarthritis (OA) is mainly characterized by the progressive destruction of articular
cartilage. Mounting studies have revealed that disruption of extracellular matrix (ECM) …